The role of patient advocacy organizations in shaping medical research: the Pompe model.
International Pompe Association (IPA)
Pompe disease
Pompe model
Journal
Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
entrez:
9
8
2019
pubmed:
9
8
2019
medline:
9
8
2019
Statut:
ppublish
Résumé
The Pompe model is the term used by the Pompe community to describe the relationship that exists between the patient community, the medical/scientific community, and industry. The development of the Pompe model represented a new paradigm for the involvement of patients in new treatments-and also for scientists and pharmaceutical companies. It saw patients developing a sense of agency, of involvement in the process of treatment development rather than powerless recipients or (if lucky) occasional spectators. At the same time, as described below, it benefited the other partners in the process with the result that the different components of the model added up to more than the sum of their parts. However, in order for this to happen, each part had to undergo a transformation in mindset. The development of enzyme replacement therapy (ERT) for Pompe disease represented a unique set of circumstances and individuals that helped to bring about this change and, in doing so, created a model that has had far wider applications.
Identifiants
pubmed: 31392205
doi: 10.21037/atm.2019.04.28
pii: atm-07-13-293
pmc: PMC6642942
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
293Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
J Pediatr. 2016 Feb;169:174-80.e1
pubmed: 26685070
J Inherit Metab Dis. 2016 May;39(3):383-390
pubmed: 26768149
Pediatrics. 2008 Jul;122(1):e39-45
pubmed: 18519449
Pediatr Neonatol. 2013 Aug;54(4):219-27
pubmed: 23632029
Neuromuscul Disord. 2015 Apr;25(4):321-32
pubmed: 25617983
Cochrane Database Syst Rev. 2017 Nov 20;11:CD011539
pubmed: 29155436
Am J Med Genet A. 2014 Jan;164A(1):54-61
pubmed: 24243590
J Neuroophthalmol. 2010 Jun;30(2):165-6
pubmed: 20404746